Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endoscopy, Gastrointestinal | 26 | 2024 | 875 | 5.220 |
Why?
|
Colonic Polyps | 17 | 2024 | 553 | 4.730 |
Why?
|
Artificial Intelligence | 28 | 2024 | 2575 | 4.160 |
Why?
|
Gastroenterology | 12 | 2024 | 580 | 3.420 |
Why?
|
Colonoscopy | 26 | 2024 | 1397 | 2.860 |
Why?
|
Diagnosis, Computer-Assisted | 10 | 2024 | 709 | 1.980 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 16 | 2024 | 507 | 1.960 |
Why?
|
Endoscopy, Digestive System | 6 | 2021 | 353 | 1.830 |
Why?
|
Endosonography | 12 | 2021 | 608 | 1.580 |
Why?
|
Pancreatic Diseases | 5 | 2021 | 344 | 1.200 |
Why?
|
Adenoma | 7 | 2022 | 2159 | 1.020 |
Why?
|
Conscious Sedation | 4 | 2016 | 532 | 0.990 |
Why?
|
Polyps | 2 | 2023 | 200 | 0.940 |
Why?
|
Juniperus | 1 | 2023 | 3 | 0.900 |
Why?
|
Endoscopy | 7 | 2023 | 1851 | 0.870 |
Why?
|
Deep Sedation | 4 | 2020 | 118 | 0.860 |
Why?
|
Duodenoscopes | 3 | 2020 | 43 | 0.810 |
Why?
|
Jaw | 1 | 2022 | 93 | 0.780 |
Why?
|
Privacy | 1 | 2023 | 233 | 0.760 |
Why?
|
Confidentiality | 2 | 2023 | 608 | 0.720 |
Why?
|
Colorectal Neoplasms | 10 | 2024 | 6927 | 0.720 |
Why?
|
Monitoring, Intraoperative | 3 | 2016 | 941 | 0.700 |
Why?
|
Surgical Instruments | 2 | 2023 | 383 | 0.700 |
Why?
|
Gastrointestinal Diseases | 4 | 2024 | 1202 | 0.670 |
Why?
|
Anesthetics, Intravenous | 2 | 2014 | 394 | 0.660 |
Why?
|
Colonography, Computed Tomographic | 1 | 2021 | 170 | 0.660 |
Why?
|
Capsule Endoscopy | 1 | 2020 | 102 | 0.650 |
Why?
|
Benchmarking | 3 | 2024 | 1045 | 0.630 |
Why?
|
Pancreatitis | 7 | 2024 | 1097 | 0.630 |
Why?
|
Barrett Esophagus | 3 | 2019 | 492 | 0.610 |
Why?
|
Disease Transmission, Infectious | 2 | 2020 | 561 | 0.590 |
Why?
|
Drainage | 6 | 2020 | 1156 | 0.590 |
Why?
|
Conflict of Interest | 1 | 2021 | 554 | 0.530 |
Why?
|
Pancreatitis, Acute Necrotizing | 2 | 2008 | 173 | 0.520 |
Why?
|
Cholangiography | 1 | 2014 | 181 | 0.470 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2014 | 31 | 0.460 |
Why?
|
Cross Infection | 2 | 2020 | 1422 | 0.450 |
Why?
|
Choledocholithiasis | 3 | 2024 | 50 | 0.450 |
Why?
|
Common Bile Duct | 1 | 2014 | 106 | 0.450 |
Why?
|
Hyperbaric Oxygenation | 1 | 2014 | 165 | 0.420 |
Why?
|
Anesthesia, General | 3 | 2023 | 1173 | 0.410 |
Why?
|
Pancreas | 5 | 2019 | 1691 | 0.410 |
Why?
|
Humans | 110 | 2024 | 760740 | 0.400 |
Why?
|
Pancreatic Ducts | 1 | 2014 | 329 | 0.400 |
Why?
|
Intestinal Polyposis | 1 | 2012 | 42 | 0.390 |
Why?
|
Propofol | 3 | 2013 | 602 | 0.360 |
Why?
|
Stents | 6 | 2020 | 3177 | 0.330 |
Why?
|
Scattering, Radiation | 1 | 2021 | 490 | 0.330 |
Why?
|
Catheterization | 1 | 2014 | 1428 | 0.330 |
Why?
|
Choristoma | 1 | 2010 | 205 | 0.320 |
Why?
|
Pancreatic Pseudocyst | 2 | 2019 | 110 | 0.320 |
Why?
|
Pancreatic Neoplasms | 5 | 2022 | 5369 | 0.320 |
Why?
|
Research Design | 3 | 2024 | 6174 | 0.310 |
Why?
|
Duodenum | 1 | 2012 | 491 | 0.310 |
Why?
|
Computers | 2 | 2021 | 591 | 0.310 |
Why?
|
Stomach | 1 | 2012 | 696 | 0.290 |
Why?
|
Clinical Competence | 1 | 2023 | 4790 | 0.280 |
Why?
|
Fiducial Markers | 2 | 2021 | 132 | 0.270 |
Why?
|
Carbapenems | 1 | 2007 | 123 | 0.260 |
Why?
|
Hypnotics and Sedatives | 2 | 2013 | 1178 | 0.260 |
Why?
|
Digestive System Diseases | 2 | 2020 | 151 | 0.260 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1727 | 0.250 |
Why?
|
Catheters, Indwelling | 1 | 2008 | 426 | 0.250 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1459 | 0.250 |
Why?
|
Delphi Technique | 3 | 2024 | 846 | 0.250 |
Why?
|
Diarrhea | 1 | 2012 | 1317 | 0.240 |
Why?
|
Arrhythmias, Cardiac | 2 | 2014 | 2234 | 0.240 |
Why?
|
Prospective Studies | 17 | 2023 | 54364 | 0.240 |
Why?
|
Anesthesia | 1 | 2016 | 1591 | 0.240 |
Why?
|
Catheterization, Peripheral | 1 | 2008 | 343 | 0.230 |
Why?
|
Catheter Ablation | 3 | 2016 | 2634 | 0.230 |
Why?
|
Cholangitis | 2 | 2024 | 111 | 0.230 |
Why?
|
Mycoses | 1 | 2007 | 386 | 0.220 |
Why?
|
Algorithms | 6 | 2024 | 14024 | 0.220 |
Why?
|
Anesthetics | 2 | 2023 | 523 | 0.220 |
Why?
|
Agrin | 2 | 2000 | 75 | 0.210 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2020 | 3356 | 0.210 |
Why?
|
Pancreatitis, Chronic | 2 | 2017 | 288 | 0.210 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3088 | 0.200 |
Why?
|
Carcinoma | 1 | 2014 | 2328 | 0.200 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3209 | 0.200 |
Why?
|
Patient Satisfaction | 2 | 2014 | 3451 | 0.200 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 2021 | 48 | 0.190 |
Why?
|
Academies and Institutes | 1 | 2023 | 318 | 0.190 |
Why?
|
Occupational Exposure | 1 | 2021 | 1813 | 0.180 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1120 | 0.180 |
Why?
|
Prisons | 1 | 2002 | 174 | 0.180 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2020 | 45 | 0.180 |
Why?
|
Pancreatic Cyst | 1 | 2024 | 367 | 0.180 |
Why?
|
Middle Aged | 35 | 2024 | 220603 | 0.170 |
Why?
|
Adenomatous Polyps | 1 | 2020 | 109 | 0.160 |
Why?
|
Aged | 30 | 2023 | 169092 | 0.160 |
Why?
|
Bile Ducts | 2 | 2023 | 282 | 0.160 |
Why?
|
Aged, 80 and over | 15 | 2021 | 58919 | 0.160 |
Why?
|
Metals | 2 | 2020 | 719 | 0.160 |
Why?
|
Colon | 2 | 2023 | 1791 | 0.150 |
Why?
|
Gallbladder | 1 | 2020 | 308 | 0.150 |
Why?
|
Plastics | 1 | 2018 | 117 | 0.150 |
Why?
|
Risk Assessment | 6 | 2024 | 23974 | 0.150 |
Why?
|
Male | 42 | 2024 | 360402 | 0.150 |
Why?
|
Needles | 1 | 2021 | 450 | 0.150 |
Why?
|
Single-Blind Method | 1 | 2021 | 1575 | 0.150 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 834 | 0.140 |
Why?
|
Prosthesis Implantation | 2 | 2019 | 591 | 0.140 |
Why?
|
Equipment Contamination | 1 | 2019 | 182 | 0.140 |
Why?
|
Retrospective Studies | 17 | 2023 | 80583 | 0.140 |
Why?
|
Precancerous Conditions | 2 | 2021 | 982 | 0.140 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3196 | 0.140 |
Why?
|
Cholangiocarcinoma | 1 | 2023 | 553 | 0.140 |
Why?
|
Pandemics | 4 | 2020 | 8652 | 0.140 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 606 | 0.140 |
Why?
|
Biliary Tract Diseases | 1 | 2017 | 159 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 391 | 0.140 |
Why?
|
Disinfection | 1 | 2019 | 207 | 0.140 |
Why?
|
Hyaluronic Acid | 1 | 2020 | 483 | 0.140 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 34 | 0.130 |
Why?
|
Esophageal Perforation | 1 | 2016 | 64 | 0.130 |
Why?
|
Gastric Bypass | 2 | 2015 | 818 | 0.130 |
Why?
|
China | 5 | 2020 | 2374 | 0.130 |
Why?
|
Equipment Design | 2 | 2022 | 3501 | 0.130 |
Why?
|
Adult | 26 | 2023 | 220995 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2020 | 633 | 0.130 |
Why?
|
Fiber Optic Technology | 1 | 2017 | 290 | 0.130 |
Why?
|
Female | 38 | 2024 | 392203 | 0.130 |
Why?
|
Capnography | 1 | 2016 | 91 | 0.130 |
Why?
|
Hemorrhage | 2 | 2019 | 3418 | 0.130 |
Why?
|
Intubation, Intratracheal | 2 | 2014 | 1331 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 6 | 2020 | 20556 | 0.130 |
Why?
|
Esophageal Neoplasms | 2 | 2016 | 1657 | 0.130 |
Why?
|
Disclosure | 1 | 2021 | 747 | 0.120 |
Why?
|
Prediabetic State | 1 | 2021 | 545 | 0.120 |
Why?
|
Thermometers | 1 | 2015 | 42 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 637 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2016 | 175 | 0.120 |
Why?
|
Lipase | 1 | 2017 | 324 | 0.120 |
Why?
|
Consensus | 3 | 2024 | 3117 | 0.110 |
Why?
|
Esophagogastric Junction | 1 | 2016 | 347 | 0.110 |
Why?
|
Ampulla of Vater | 1 | 2014 | 149 | 0.110 |
Why?
|
Tidal Volume | 1 | 2016 | 488 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1386 | 0.110 |
Why?
|
Peritonitis | 1 | 2016 | 368 | 0.110 |
Why?
|
Triage | 1 | 2020 | 984 | 0.110 |
Why?
|
Oximetry | 1 | 2016 | 459 | 0.110 |
Why?
|
Jejunum | 1 | 2015 | 472 | 0.110 |
Why?
|
Evoked Potentials, Auditory | 1 | 2016 | 530 | 0.110 |
Why?
|
Risk Factors | 11 | 2024 | 74128 | 0.110 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2010 | 4575 | 0.100 |
Why?
|
Blood Pressure | 2 | 2020 | 8473 | 0.100 |
Why?
|
Hemobilia | 1 | 2012 | 18 | 0.100 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 527 | 0.100 |
Why?
|
Gastritis, Hypertrophic | 1 | 2012 | 9 | 0.100 |
Why?
|
Cutaneous Fistula | 1 | 2012 | 79 | 0.100 |
Why?
|
Hepatitis C | 1 | 2002 | 1580 | 0.100 |
Why?
|
Ageusia | 1 | 2012 | 18 | 0.100 |
Why?
|
Young Adult | 10 | 2020 | 59191 | 0.100 |
Why?
|
BRCA2 Protein | 1 | 2017 | 797 | 0.100 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3882 | 0.100 |
Why?
|
Cystic Duct | 1 | 2011 | 18 | 0.100 |
Why?
|
Gastric Fistula | 1 | 2012 | 73 | 0.100 |
Why?
|
Intestinal Fistula | 1 | 2012 | 142 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 75 | 0.100 |
Why?
|
Leiomyoma | 1 | 2016 | 636 | 0.100 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 509 | 0.090 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 791 | 0.090 |
Why?
|
Bile Duct Diseases | 1 | 2011 | 97 | 0.090 |
Why?
|
Balloon Occlusion | 1 | 2012 | 125 | 0.090 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2533 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 739 | 0.090 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20077 | 0.090 |
Why?
|
Foreign-Body Migration | 1 | 2012 | 219 | 0.090 |
Why?
|
Hypertension | 1 | 2011 | 8532 | 0.090 |
Why?
|
Depression | 1 | 2010 | 8132 | 0.090 |
Why?
|
Group Processes | 1 | 2012 | 228 | 0.090 |
Why?
|
Physicians | 2 | 2024 | 4583 | 0.090 |
Why?
|
Crohn Disease | 1 | 2023 | 2279 | 0.090 |
Why?
|
Anesthesia Recovery Period | 1 | 2011 | 155 | 0.090 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1927 | 0.090 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3527 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14649 | 0.090 |
Why?
|
Gastrostomy | 1 | 2012 | 323 | 0.090 |
Why?
|
Cryosurgery | 1 | 2015 | 468 | 0.090 |
Why?
|
Alzheimer Disease | 5 | 2006 | 8603 | 0.080 |
Why?
|
Nursing Staff | 1 | 2010 | 113 | 0.080 |
Why?
|
Pulmonary Veins | 1 | 2015 | 716 | 0.080 |
Why?
|
Biopsy | 3 | 2021 | 6763 | 0.080 |
Why?
|
Gallstones | 1 | 2011 | 284 | 0.080 |
Why?
|
Esophagus | 1 | 2015 | 1031 | 0.080 |
Why?
|
Pathology | 1 | 2012 | 269 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2021 | 273 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2143 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1263 | 0.080 |
Why?
|
Incidence | 5 | 2023 | 21339 | 0.080 |
Why?
|
Hypotension | 1 | 2014 | 879 | 0.070 |
Why?
|
Mass Screening | 2 | 2021 | 5425 | 0.070 |
Why?
|
Alopecia | 1 | 2012 | 412 | 0.070 |
Why?
|
Ultrasonography, Interventional | 3 | 2020 | 1496 | 0.070 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1116 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10203 | 0.070 |
Why?
|
Lasers | 1 | 2021 | 952 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6390 | 0.070 |
Why?
|
Treatment Outcome | 10 | 2021 | 64572 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2917 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12043 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6339 | 0.070 |
Why?
|
Cohort Studies | 5 | 2021 | 41464 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12966 | 0.060 |
Why?
|
Hemodynamics | 1 | 2016 | 4160 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3310 | 0.060 |
Why?
|
Light | 1 | 2021 | 1352 | 0.060 |
Why?
|
Necrosis | 2 | 2020 | 1610 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9277 | 0.060 |
Why?
|
Time Factors | 5 | 2022 | 39908 | 0.060 |
Why?
|
Heart Rate | 1 | 2016 | 4181 | 0.060 |
Why?
|
Fatigue | 1 | 2012 | 1550 | 0.060 |
Why?
|
Teaching | 1 | 2012 | 1169 | 0.060 |
Why?
|
Prothrombin | 2 | 2006 | 190 | 0.060 |
Why?
|
Liver | 2 | 2021 | 7512 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2709 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2020 | 1185 | 0.050 |
Why?
|
Electrocardiography | 1 | 2016 | 6346 | 0.050 |
Why?
|
Blood-Borne Pathogens | 1 | 2002 | 52 | 0.050 |
Why?
|
Education, Medical, Undergraduate | 1 | 2012 | 1070 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5838 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15250 | 0.050 |
Why?
|
Liability, Legal | 1 | 2024 | 210 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 88247 | 0.050 |
Why?
|
Rhode Island | 1 | 2002 | 351 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7403 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 296 | 0.050 |
Why?
|
Apolipoproteins E | 2 | 2006 | 1443 | 0.050 |
Why?
|
Case Management | 1 | 2002 | 272 | 0.050 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 587 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2023 | 452 | 0.050 |
Why?
|
Ribavirin | 1 | 2002 | 392 | 0.050 |
Why?
|
Electroencephalography | 1 | 2016 | 6240 | 0.040 |
Why?
|
Health Surveys | 1 | 2010 | 4036 | 0.040 |
Why?
|
Capillaries | 2 | 2002 | 756 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2015 | 6345 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2682 | 0.040 |
Why?
|
United States | 4 | 2021 | 72292 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2006 | 3798 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2023 | 659 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2006 | 1027 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39062 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2006 | 1474 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2023 | 414 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2024 | 15609 | 0.040 |
Why?
|
Clinical Alarms | 1 | 2020 | 61 | 0.040 |
Why?
|
Equipment Reuse | 1 | 2019 | 45 | 0.040 |
Why?
|
Interferons | 1 | 2002 | 702 | 0.040 |
Why?
|
Prevalence | 3 | 2017 | 15702 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 487 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 768 | 0.040 |
Why?
|
Laminin | 1 | 2000 | 408 | 0.040 |
Why?
|
Computer Systems | 1 | 2019 | 469 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7236 | 0.040 |
Why?
|
Choroid Plexus | 1 | 2001 | 240 | 0.040 |
Why?
|
Substance Abuse, Intravenous | 1 | 2002 | 529 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2001 | 544 | 0.040 |
Why?
|
Databases, Factual | 3 | 2018 | 7963 | 0.040 |
Why?
|
Checklist | 1 | 2024 | 827 | 0.040 |
Why?
|
Body Fluids | 1 | 2019 | 320 | 0.040 |
Why?
|
Immunohistochemistry | 5 | 2006 | 11069 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9310 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2021 | 276 | 0.030 |
Why?
|
Endoscopes | 1 | 2017 | 168 | 0.030 |
Why?
|
Debridement | 1 | 2019 | 493 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 36401 | 0.030 |
Why?
|
Patients | 1 | 2023 | 906 | 0.030 |
Why?
|
Carboxypeptidases | 1 | 1996 | 155 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5031 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2000 | 960 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2021 | 533 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 744 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1603 | 0.030 |
Why?
|
Patient Discharge | 1 | 2008 | 3442 | 0.030 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 571 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2047 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1300 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1635 | 0.030 |
Why?
|
Microcirculation | 1 | 1999 | 1272 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1204 | 0.030 |
Why?
|
Patient Readmission | 1 | 2008 | 3269 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1000 | 0.030 |
Why?
|
Basement Membrane | 2 | 2006 | 349 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2607 | 0.030 |
Why?
|
Sus scrofa | 1 | 2015 | 428 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1912 | 0.030 |
Why?
|
Cicatrix | 1 | 2019 | 785 | 0.030 |
Why?
|
Gastric Mucosa | 1 | 2016 | 603 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2015 | 398 | 0.030 |
Why?
|
Nursing Homes | 1 | 2020 | 1083 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2017 | 494 | 0.030 |
Why?
|
Anesthesia, Inhalation | 1 | 2013 | 220 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 30015 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 708 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1996 | 1606 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2023 | 15829 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2114 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 982 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1748 | 0.020 |
Why?
|
Lithotripsy | 1 | 2011 | 140 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3575 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2780 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22153 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2002 | 3037 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 1999 | 2726 | 0.020 |
Why?
|
Heart Atria | 1 | 2015 | 1333 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2635 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1409 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8426 | 0.020 |
Why?
|
Problem-Based Learning | 1 | 2012 | 356 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4237 | 0.020 |
Why?
|
Bacteria | 1 | 2019 | 2192 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6418 | 0.020 |
Why?
|
Hippocampus | 1 | 2000 | 3762 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2012 | 794 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2000 | 3839 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5292 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2006 | 119 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2011 | 770 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12333 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1116 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5908 | 0.020 |
Why?
|
Fatty Liver | 1 | 2011 | 787 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1505 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13248 | 0.010 |
Why?
|
Software | 1 | 2018 | 4432 | 0.010 |
Why?
|
Factor VIII | 1 | 2006 | 348 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6961 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7390 | 0.010 |
Why?
|
Radiosurgery | 1 | 2013 | 1339 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2486 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8209 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8619 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10507 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4615 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2006 | 927 | 0.010 |
Why?
|
Arachnoid | 1 | 2001 | 50 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2515 | 0.010 |
Why?
|
Models, Statistical | 1 | 2015 | 5074 | 0.010 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2001 | 191 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 255 | 0.010 |
Why?
|
Neurons | 1 | 1999 | 9436 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12934 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 748 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26065 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2001 | 592 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168202 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 673 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8835 | 0.010 |
Why?
|
Lymphokines | 1 | 2001 | 925 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6223 | 0.010 |
Why?
|
Disease Progression | 2 | 2006 | 13495 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1089 | 0.010 |
Why?
|
Pteroylpolyglutamic Acids | 1 | 1996 | 9 | 0.010 |
Why?
|
gamma-Glutamyl Hydrolase | 1 | 1996 | 8 | 0.010 |
Why?
|
Polyglutamic Acid | 1 | 1996 | 47 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29601 | 0.010 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 1996 | 82 | 0.010 |
Why?
|
Cell Fractionation | 1 | 1996 | 249 | 0.010 |
Why?
|
Hydrolases | 1 | 1996 | 147 | 0.010 |
Why?
|
Amyloid | 1 | 2001 | 841 | 0.010 |
Why?
|
Child | 1 | 2023 | 80089 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2001 | 865 | 0.010 |
Why?
|
Hydrocephalus | 1 | 2001 | 764 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 12942 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1996 | 1790 | 0.010 |
Why?
|
Brain | 1 | 1999 | 27100 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2002 | 2219 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4919 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1996 | 2495 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5776 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2001 | 3492 | 0.010 |
Why?
|
Methotrexate | 1 | 1996 | 1716 | 0.010 |
Why?
|
Folic Acid | 1 | 1996 | 1323 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 6126 | 0.000 |
Why?
|
Genotype | 1 | 2002 | 12977 | 0.000 |
Why?
|
Cell Membrane | 1 | 1996 | 3680 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2002 | 8998 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1996 | 11107 | 0.000 |
Why?
|